CEFIXIME | A065130 | LUPIN PHARMACEUTICALS INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Lupin Pharmaceuticals, Inc. - Citizen Petition FDA-2008-P-0534 · 3 docket documents Lupin Pharmaceuticals, Inc. filed this suitability petition requesting FDA approval to submit an abbreviated new drug application for Cefixime Capsules in 200 mg and 400 mg strengths, which would differ from the reference listed drug Suprax tablets only in dosage form, with the same active ingredien | Other | 2008-10-07 | Withdrawn | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.